Exhaustive laboratory tests in the United States have shown that a drug currently used for the treatment of arthritis can be effective in treating some forms of cancer.
SV INTERIOR Laboratory technicians taking rats from stacked trays; rats being examined. (3 SHOTS)
SV Dr. Morris Blount talking in lab to university student.
CU White rat in plastic cage.
CU Dr. Blount speaking to reporter.
CU PAN Dr. Blount holding white rat on table.
CU Technician preparing liquid feeds for rats. (3 SHOTS)
TRANSCRIPT: BLOUNT: "By giving blocking agents for prostaglandin we can interfere with many other tumours. So we think that prostaglandins are basically a very broad mechanism in...in tumourogenesis."
RAY: "So you're saying prostaglandins possibly play a role in the development of tumours elsewhere in the body, not necessarily just (INDISTINCT).."
BLOUNT: "We have some evidence that this is true."
Script is copyright Reuters Limited. All rights reserved
Background: Exhaustive laboratory tests in the United States have shown that a drug currently used for the treatment of arthritis can be effective in treating some forms of cancer. The research at Notre Dame University in South Bend, Indiana, has so far been restricted to laboratory rats. The tests have however, shown that indomethacin, which is used to treat arthritis, prevents the formation of cancerous tumours by interfering with the cancer-causing hormone, prostaglandin. In tests laboratory rats suffering from intestinal cancer have their water supply laced with indomethacin. The incidence of tumours in the rats has as a result now been reduced by 90 per cent. Dr. Morris Blount, who is leading the research, says the tests have revealed some evidence to show the importance of prostaglandins in cancer formation. He was talking to NBC News reporter Cathy Ray.